Trials / Completed
CompletedNCT00417937
A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily
A Multicenter, Double-Blind Clinical Trial to Assess the Efficacy and Tolerability of Topical Azelaic Acid 15% Gel Once Daily Compared to Topical Azelaic Acid 15% gelTwice Daily in Subjects With Papulopustular Rosacea
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 98 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the efficacy and tolerability of azelaic acid 15% gel applied once daily versus twice daily in the treatment of patients with papulopustular rosacea.
Detailed description
To test the efficacy and safety of once vs twice daily application of azelaic acid 15% gel on papulopustular rosacea
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | azelaic acid 15% gel | 15% gel, topically applied once daily for six weeks |
| DRUG | azelaic acid 15% gel | 15% gel, topically applied twice daily for six weeks |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2007-01-04
- Last updated
- 2023-06-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00417937. Inclusion in this directory is not an endorsement.